Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe revision label was updated from v3.6.4 to v3.6.5 to reflect a newer page version. It represents an internal metadata update and does not change the study information presented.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe study page now shows revision v3.6.4, replacing the previous v3.6.3, indicating an updated version of the page content.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's revision indicator was updated from Revision: v3.6.0 to Revision: v3.6.3, reflecting a small platform update to the study detail page.SummaryDifference0.0%

- Check77 days agoChange DetectedRecruitment status updated to indicate the study is no longer seeking participants. The page now includes guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a standardized 'Intervention/Treatment' label, alongside a revision note 'Revision: v3.6.0' and removal of the previous 'Revision: v3.5.5' version.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page’s revision label updated to v3.5.5, signaling a backend or CMS update rather than a change to the study details or visible content.SummaryDifference0.0%

- Check106 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a behind-the-scenes update to the page or system. The study content and user-facing information appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.